TGRNF (Tong Ren Tang Technologies Co) Beneish M-Score: -3.12 (As of Jul. 02, 2026)


TGRNF Tong Ren Tang Technologies Co Ltd TGRNF
50 GF Score
Price $0.49
GF Value $0.84
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Tong Ren Tang Technologies Co Beneish M-Score?

Tong Ren Tang Technologies Co TGRNF 50 Beneish M-Score is -3.12 as of Jul. 02, 2026. GuruFocus rates TGRNF with a GF Score™ of 50/100 and a GF Value™ of $0.84 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 909 Drug Manufacturers companies, Tong Ren Tang Technologies Co ranks better than 85.81% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.12 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Tong Ren Tang Technologies Co's Beneish M-Score or its related term are showing as below:

TGRNF' s Beneish M-Score Range Over the Past 10 Years
Min: -3.12   Med: -2.51   Max: -1.9
Current: -3.12

During the past 13 years, the highest Beneish M-Score of Tong Ren Tang Technologies Co was -1.90. The lowest was -3.12. And the median was -2.51.


Tong Ren Tang Technologies Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Tong Ren Tang Technologies Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tong Ren Tang Technologies Co Beneish M-Score Chart

Tong Ren Tang Technologies Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.46 -2.43 -2.81 -2.00 -3.12

Tong Ren Tang Technologies Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.81 0.00 -2.00 0.00 -3.12

TGRNF vs LLY, JNJ, ABBV: Beneish M-Score Comparison

For the Drug Manufacturers - General subindustry, Tong Ren Tang Technologies Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tong Ren Tang Technologies Co Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tong Ren Tang Technologies Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Tong Ren Tang Technologies Co's Beneish M-Score falls into.


TGRNF
50GF Score
Tong Ren Tang Technologies Co Ltd TGRNF
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tong Ren Tang Technologies Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Tong Ren Tang Technologies Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.6811+0.528 * 1.0424+0.404 * 1.1454+0.892 * 0.9233+0.115 * 0.858
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9519+4.679 * -0.085054-0.327 * 0.8473
=-3.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was $95.3 Mil.
Revenue was $920.6 Mil.
Gross Profit was $350.1 Mil.
Total Current Assets was $1,447.1 Mil.
Total Assets was $1,946.7 Mil.
Property, Plant and Equipment(Net PPE) was $451.3 Mil.
Depreciation, Depletion and Amortization(DDA) was $47.4 Mil.
Selling, General, & Admin. Expense(SGA) was $227.8 Mil.
Total Current Liabilities was $252.8 Mil.
Long-Term Debt & Capital Lease Obligation was $219.3 Mil.
Net Income was $56.3 Mil.
Gross Profit was $0.0 Mil.
Cash Flow from Operations was $221.8 Mil.
Total Receivables was $151.6 Mil.
Revenue was $997.1 Mil.
Gross Profit was $395.2 Mil.
Total Current Assets was $1,488.0 Mil.
Total Assets was $1,979.0 Mil.
Property, Plant and Equipment(Net PPE) was $448.2 Mil.
Depreciation, Depletion and Amortization(DDA) was $39.8 Mil.
Selling, General, & Admin. Expense(SGA) was $259.2 Mil.
Total Current Liabilities was $390.3 Mil.
Long-Term Debt & Capital Lease Obligation was $176.2 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(95.313 / 920.587) / (151.574 / 997.108)
=0.103535 / 0.152014
=0.6811

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(395.221 / 997.108) / (350.055 / 920.587)
=0.396367 / 0.380252
=1.0424

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1447.076 + 451.303) / 1946.674) / (1 - (1487.972 + 448.176) / 1979.012)
=0.024809 / 0.021659
=1.1454

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=920.587 / 997.108
=0.9233

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(39.783 / (39.783 + 448.176)) / (47.385 / (47.385 + 451.303))
=0.081529 / 0.095019
=0.858

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(227.814 / 920.587) / (259.218 / 997.108)
=0.247466 / 0.25997
=0.9519

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((219.31 + 252.849) / 1946.674) / ((176.216 + 390.274) / 1979.012)
=0.242547 / 0.286249
=0.8473

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(56.264 - 0 - 221.836) / 1946.674
=-0.085054

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Tong Ren Tang Technologies Co has a M-score of -3.12 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.12 mean?
Tong Ren Tang Technologies Co (TGRNF) has a Beneish M-Score of -3.12 as of Jul. 02, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Tong Ren Tang Technologies Co and its competitors. According to the industry distribution chart, Tong Ren Tang Technologies Co ranks #129 out of 909 companies in the Drug Manufacturers industry, placing it in the top 14.2%.
Is Tong Ren Tang Technologies Co's Beneish M-Score too high?
Tong Ren Tang Technologies Co's current Beneish M-Score is -3.12. Based on the distribution chart, Tong Ren Tang Technologies Co ranks #129 out of 909 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Tong Ren Tang Technologies Co has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tong Ren Tang Technologies Co's Beneish M-Score compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Tong Ren Tang Technologies Co ranks #129 out of 909 companies for Beneish M-Score. This places Tong Ren Tang Technologies Co in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Tong Ren Tang Technologies Co and its competitors. Tong Ren Tang Technologies Co's current Beneish M-Score is -3.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tong Ren Tang Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Tong Ren Tang Technologies Co (TGRNF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.84, compared to a current price of $0.49 — trading 41.1% below its estimated fair value. The current Beneish M-Score is -3.12. Tong Ren Tang Technologies Co's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Tong Ren Tang Technologies Co (TGRNF), the current Beneish M-Score is -3.12 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tong Ren Tang Technologies Co (TGRNF) Overvalued in 2026?

Based on GuruFocus' analysis, Tong Ren Tang Technologies Co stock appears to be undervalued. The current stock price of $0.49 is trading 41.1% below its estimated GF Value™ of $0.84. GuruFocus considers Tong Ren Tang Technologies Co to be Significantly Undervalued.

Key valuation signals for TGRNF:

  • Beneish M-Score: -3.12
  • GF Value™: $0.84 vs. price of $0.49 (41.1% below fair value)
  • GF Score™: 50/100 with 5 warning signs

No single metric tells the full story. See the TGRNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tong Ren Tang Technologies Co Business Description

Other Exchanges 01666:Hong KongTNG:Germany
Address No. 16 Tongji Beilu, Beijing Economic and Technological Development Zone, Beijing, CHN
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
50GF Score

Get the complete analysis for TGRNF

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.49
Price
$0.84
GF Value